Now he is a member of various professional organizations in China, the editorial board of several magazines, the chairman of Jiangsu Branch of Chinese Medical Association, and the member of Hematology Society. Deputy director of Jiangsu Branch of China Pathophysiology Society, director of Jiangsu Society of Biochemistry and Molecular Biology, member of Standing Committee of Hematology and Oncology Committee of China Anti-Cancer Association, member of Standing Committee of Experimental Hematology Committee of China Pathophysiology Society, and member of pharmaceutical biotechnology Clinical Application Committee of China Medical Biotechnology Association. Member of American Society of Hematology, American Association for Cancer Research (AACR) and International Society of Experimental Hematology (ISEH). Member of the Expert Group for Discipline Evaluation of the Department of Life Sciences, National Natural Science Foundation of China. He was once rated as a model worker in Jiangsu Province and an outstanding party member in Jiangsu universities. He has won the Rockefeller Foundation Biotechnology Scholarship, the second prize of provincial scientific and technological progress 1 item, and the third prize of provincial and ministerial scientific and technological progress. And for three consecutive years (1994- 1996), the information research institute of the state SCIence and technology commission ranked first according to the citation number of single papers counted by sci.
Projects under study:
1, Study on Abnormal Transcription of Leukemia Cells, supported by Natural Science Foundation of Jiangsu Province (BK2004040) 65,000 yuan (2004-2007).
2. Experimental study on gene expression profile and molecular mechanism of myelodysplastic syndrome by gene chip technology, National Natural Science Foundation of China (30470733) 2 1 10,000 yuan (2005-2007).
3. Study on Extramedullary Infiltration Mechanism and Intervention Strategy of Leukemia Cells, supported by National Natural Science Foundation of China (30670905), with a total investment of 280,000 yuan (2007, 1-2009, 12).
4. National High-tech Research and Development Plan for Molecular Typing and Individualized Diagnosis and Treatment of Acute Leukemia (863 Plan)
(2006AA02A405) Sub-topic 1.46 million yuan 2007-20 10. Study on effective transduction and * * * expression of ALDH 1 gene and mdr 1 gene by retrovirus bicistronic strategy
Generalization of fixed point minimax theorem
Study on the control of mdr 1 expression by internal ribosome entry site
Author: Chen Zixing Yang
Press: Chemical Industry Press
Release date: June 2004-1
Page count: 374 pages
Words: 598000
Paper: offset paper
Industrial and commercial bank number: 9787502548629
Packing: paperback